a-Tetrahydrocortisol

Cortisol is the hormone your body uses to manage stress, regulate blood sugar, and quiet inflammation. A standard cortisol blood test tells you how much is circulating at one moment, but it cannot tell you how efficiently your body is breaking that cortisol down once the job is done. That cleanup process matters, because the same cortisol output can produce very different effects on your blood pressure, weight, and metabolism depending on how it is metabolized.

α-THF (alpha-tetrahydrocortisol) is one of the main cortisol breakdown products your body produces, and it shows up in urine. Tracked alongside its sister metabolites, it offers a window into the enzymes that control cortisol activity in your tissues. This is a research-grade marker without universal clinical cutoffs, so it is most useful as part of a broader urine steroid profile and as a trend tracked over time.

What This Test Is Actually Measuring

When cortisol finishes its work, the body inactivates it through a series of enzyme steps. One enzyme, called 5α-reductase, converts cortisol into α-THF. A second enzyme path produces a near-twin called β-tetrahydrocortisol (β-THF). A third path converts cortisone (the inactive form of cortisol) into tetrahydrocortisone (THE).

On its own, the α-THF number is hard to interpret. Its value comes from being read in combination with the other two metabolites. The most important readout from this profile is the ratio (THF + α-THF) / THE, which serves as a rough indicator of an enzyme system called 11β-HSD2. When that enzyme is working properly, it converts active cortisol into inactive cortisone, protecting your kidneys and blood vessels from the blood pressure-raising effects of cortisol.

Heart and Blood Pressure Risk

The clearest clinical signal from α-THF and its companion metabolites is around blood pressure. People with untreated essential hypertension tend to show a higher (THF + α-THF) / THE ratio and a higher α-THF / THF ratio, patterns consistent with reduced 11β-HSD2 activity and altered cortisol breakdown.

In one analysis of hypertensive patients and people with primary aldosteronism, a (THF + α-THF) / THE ratio above 1.5 marked a subgroup at higher risk of organ damage from excess mineralocorticoid activity. A separate study of prednisone-treated patients found that a urinary cortisol-to-cortisone metabolite ratio above 1.5 was associated with roughly 3.8 times the odds of hypertension after steroid therapy, with the effect most pronounced in those with severe blood pressure elevation. In obese children, higher excretion of cortisol metabolites including α-THF tracked with greater 24-hour blood pressure load.

What this means for you: an elevated ratio is not a diagnosis of high blood pressure, but in someone with borderline or hard-to-control blood pressure, it can point toward a mineralocorticoid-driven mechanism that benefits from a different drug class than first-line antihypertensives.

Apparent Mineralocorticoid Excess

In a rare inherited condition called apparent mineralocorticoid excess (AME), the 11β-HSD2 enzyme is severely impaired. The metabolite profile looks dramatic: THF and α-THF are markedly elevated relative to THE. The condition causes severe hypertension, often in childhood, with low potassium. While most adults reading this will not have AME, the same metabolic pattern in a milder form may contribute to subgroups of essential hypertension that resist standard treatment.

PCOS and Insulin Resistance

Women with polycystic ovary syndrome (PCOS) often show an increased 5α-THF / 5β-THF ratio along with altered overall cortisol metabolism, consistent with elevated 5α-reductase activity. Insulin appears to drive this shift: in PCOS, higher insulin levels enhance 5α-reduction, increasing α-THF output without raising total cortisol production. This makes the metabolite pattern part of the metabolic signature of PCOS rather than a marker of adrenal disease per se.

Body Weight, Nutrition, and Stress States

Body composition shifts these metabolites in measurable ways. In moderately obese women, total urinary cortisol metabolites, especially 5α-THF and 5β-THF, were elevated, with increased reactivation of cortisol in fat tissue and reduced reactivation in the liver. Obese children also show higher excretion of α-THF and related metabolites compared with normal-weight peers.

The pattern goes the other way in severe undernutrition. Women with anorexia nervosa show reduced 5α-THF and a lower 5α/5β-THF ratio, both of which normalize after refeeding. This tells you that the metabolite is responsive to nutritional state, not just to disease, and that interpreting a single result without context about body weight and intake is a mistake.

Sex Differences You Should Know About

Women excrete less 5α-THF and 5β-THF than men, even when cortisol and cortisone outputs are similar. The difference comes from lower activity of the A-ring reduction enzymes in women, not from any difference in total cortisol production. Reference comparisons that ignore sex will mislead. Compare your result to ranges for your sex, and ideally to your own previous results.

Reference Ranges

α-THF is a research and specialty-lab marker without universally standardized clinical cutpoints. The values below are framed as orientation, drawn from how labs running urine steroid profiles typically report and how studies of the (THF + α-THF) / THE ratio define risk thresholds. Your lab will likely report different numbers and may use different units depending on the method used.

Treat any single value with caution. The ratios above come from research cohorts and clinical case series, not from broad reference populations. Compare results within the same lab over time for the most meaningful trend.

Tracking Your Trend

Cortisol metabolism varies day to day, and α-THF follows clear circadian and ultradian rhythms across a 24-hour window. A single reading captures one snapshot of a moving system. The DUTCH-style dried urine method already smooths this out by sampling at four points across a day, but biological variation between weeks is still real. Tracking your trend is more informative than fixating on one number.

A reasonable cadence: get a baseline, then retest in 3 to 6 months if you are changing diet, body weight, sleep, or starting or stopping a medication that affects cortisol metabolism. After that, an annual check is enough for most people to detect drift before it becomes clinically meaningful.

What to Do With an Abnormal Result

An isolated α-THF reading should not drive a clinical decision on its own. If the (THF + α-THF) / THE ratio is elevated alongside hard-to-control blood pressure, low potassium, or unexplained weight gain, that combination is worth investigating with serum aldosterone, plasma renin activity, and 24-hour urinary free cortisol. An endocrinologist or hypertension specialist can sort through whether the pattern reflects an enzyme issue, mineralocorticoid excess, or downstream effects of insulin resistance.

If the α-THF / THF ratio is high in a woman with irregular cycles or signs of androgen excess, the broader PCOS workup (testosterone, DHEA-S, fasting insulin, glucose tolerance) is the next step. In someone with classic adrenal insufficiency on hydrocortisone replacement, an abnormal metabolite ratio may point toward a regimen that is overshooting normal cortisol metabolism, which can be addressed with timing or formulation changes.

When Results Can Be Misleading

A handful of factors can distort a single reading without reflecting real changes in cortisol metabolism:

• Licorice consumption: real licorice (containing glycyrrhetinic acid) inhibits the 11β-HSD2 enzyme and shifts the (THF + α-THF) / THE ratio upward within days. The shift mimics a disease pattern without any underlying disease.
• Steroid-modifying drugs: ketoconazole and metyrapone, used in Cushing's syndrome, broadly remodel the urinary steroid profile and can produce misleading metabolite patterns. Pegvisomant for acromegaly raises the (THF + α-THF) / THE ratio. Potent androgen receptor blockers used in prostate cancer (enzalutamide, apalutamide) suppress renal 11β-HSD2 and shift the ratio upward as a side effect.
• Kidney disease: advanced chronic kidney disease and hemodialysis alter cortisol metabolite excretion and reduce apparent 11β-HSD activity on these tests. The change reflects altered clearance, not necessarily altered tissue cortisol biology.
• Collection errors: missing one of the four daily samples, mistiming the bedtime collection, or letting the strips dry incompletely can throw off both absolute values and ratios.

Putting It in Context

α-THF is one of the more nuanced numbers in a urine steroid profile. It does not replace a serum cortisol, a 24-hour urinary free cortisol, or a salivary cortisol curve. It complements them by adding metabolic context. If you order this test, order it as part of a panel that also reports cortisol, cortisone, β-THF, and THE, because the ratios are what carry the clinical signal.